WO1996017927A3 - Reporter cell line - Google Patents

Reporter cell line Download PDF

Info

Publication number
WO1996017927A3
WO1996017927A3 PCT/EP1995/004819 EP9504819W WO9617927A3 WO 1996017927 A3 WO1996017927 A3 WO 1996017927A3 EP 9504819 W EP9504819 W EP 9504819W WO 9617927 A3 WO9617927 A3 WO 9617927A3
Authority
WO
WIPO (PCT)
Prior art keywords
nfλb
expression
cell line
gene
gene product
Prior art date
Application number
PCT/EP1995/004819
Other languages
French (fr)
Other versions
WO1996017927A2 (en
Inventor
Stefan Nilsson
Original Assignee
Karobio Ab
Stefan Nilsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karobio Ab, Stefan Nilsson filed Critical Karobio Ab
Priority to AU47134/96A priority Critical patent/AU4713496A/en
Publication of WO1996017927A2 publication Critical patent/WO1996017927A2/en
Publication of WO1996017927A3 publication Critical patent/WO1996017927A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a cell line including a first reporter gene arranged to express an assayable first gene product, expression of the first reporter gene being AP-1 mediated, and a second reporter gene arranged to express a second assayable gene product, expression of the second reporter gene being mediated by NFλB. Thus the present invention provides a convenient one cell line-based assay system which can be used to rapidly test a large number of compounds for potential anti-inflammatory activity. According to a further aspect of the invention there is provided a method of testing a compound for both AP1 and NFλB inhibitory activity, the method comprising providing cells in accordance with the first aspect of the invention, stimulating AP1 and NFλB activity in the cells and contacting the cells with the compound to be tested and monitoring expression of the first and second gene products wherein inhibition of AP1 expression of the first gene product, and inhibition of NFλB mediated expression of the second gene product is indicative that the compound has both AP1 and NFλB-inhibitory activity.
PCT/EP1995/004819 1994-12-05 1995-12-05 Reporter cell line WO1996017927A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU47134/96A AU4713496A (en) 1994-12-05 1995-12-05 Reporter cell line

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9424497A GB9424497D0 (en) 1994-12-05 1994-12-05 Reporter cell line
GB9424497.7 1994-12-05

Publications (2)

Publication Number Publication Date
WO1996017927A2 WO1996017927A2 (en) 1996-06-13
WO1996017927A3 true WO1996017927A3 (en) 1996-08-29

Family

ID=10765423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/004819 WO1996017927A2 (en) 1994-12-05 1995-12-05 Reporter cell line

Country Status (3)

Country Link
AU (1) AU4713496A (en)
GB (1) GB9424497D0 (en)
WO (1) WO1996017927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1157126A4 (en) * 1999-02-24 2005-03-02 Gen Hospital Corp Method for cloning signal transduction intermediates
WO2003048202A2 (en) * 2001-12-03 2003-06-12 Asahi Kasei Pharma Corporation Nf-kappab activating genes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007072A1 (en) * 1990-10-10 1992-04-30 La Jolla Cancer Research Foundation Method of inhibiting transcription utilizing nuclear receptors
WO1994017208A1 (en) * 1993-01-21 1994-08-04 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
DE4311835A1 (en) * 1993-04-07 1994-10-13 Boehringer Ingelheim Int Method for inhibiting gene transcription
WO1995006754A1 (en) * 1993-09-01 1995-03-09 The Regents Of The University Of California Methods for screening antiestrogen compounds
WO1995031722A1 (en) * 1994-05-18 1995-11-23 Ligand Pharmaceuticals, Inc. Screening for cytokine modulators

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007072A1 (en) * 1990-10-10 1992-04-30 La Jolla Cancer Research Foundation Method of inhibiting transcription utilizing nuclear receptors
WO1994017208A1 (en) * 1993-01-21 1994-08-04 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
DE4311835A1 (en) * 1993-04-07 1994-10-13 Boehringer Ingelheim Int Method for inhibiting gene transcription
WO1995006754A1 (en) * 1993-09-01 1995-03-09 The Regents Of The University Of California Methods for screening antiestrogen compounds
WO1995031722A1 (en) * 1994-05-18 1995-11-23 Ligand Pharmaceuticals, Inc. Screening for cytokine modulators

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A. RAY AND K.E. PREFONTAINE: "Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor", PROC. NATL.ACAD SCI., vol. 91, January 1994 (1994-01-01), NATL. ACAD SCI.,WASHINGTON,DC,US;, pages 752 - 756, XP002004799 *
ALAM J ET AL: "REPORTER GENES: APPLICATION TO THA STUDY OF MAMMALIAN GENE TRANSCRIPTION", ANALYTICAL BIOCHEMISTRY, vol. 188, no. 2, 1 August 1990 (1990-08-01), pages 245 - 254, XP000563914 *
C. JONAT ET AL.: "Antitumor promotion and antiinflammation: Down-modulation of AP-1(Fos/Jun) activity by glucocorticoid hormone", CELL, vol. 62, 21 September 1990 (1990-09-21), CELL PRESS,CAMBRIDGE,MA,US;, pages 1189 - 1204, XP002004798 *

Also Published As

Publication number Publication date
WO1996017927A2 (en) 1996-06-13
GB9424497D0 (en) 1995-01-25
AU4713496A (en) 1996-06-26

Similar Documents

Publication Publication Date Title
ATE260989T1 (en) INSIGHTS FROM GENOME RESEARCH FOR THE SEARCH FOR NOVEL ACTIVE INGREDIENTS
WO1999039001A3 (en) Nucleic acid analysis method
EP0133671A3 (en) Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore
AU6837287A (en) Amplified hybridization assay
CA2202154A1 (en) Methods for drug screening
CA2152498A1 (en) Method, test article, and system for performing assays
ATE79474T1 (en) METHODS FOR IN VITRO DETECTION AND DETERMINATION OF UNKNOWN PATHOGENS OR GENETIC UNITS.
EP0370719A3 (en) Extended nucleotide sequences
EP0874913A4 (en) Multiple reporter gene assay
AU7222698A (en) Method of preparing a standard diagnostic gene transcript pattern
HK1096151A1 (en) Devices and methods relating to electrochemical biosensors
IL71715A0 (en) Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization
AUPQ422399A0 (en) Method of screening transformed or transfected cells
ES8900235A1 (en) Method for performing nucleic acid hybridization assays.
FI953990A (en) A method of rendering a nucleic acid amplification reaction product incapable of further amplification, a diagnostic assay method using this method, and a test kit and container suitable for performing the method or assay.
WO1993020230A1 (en) Electrochemical detection of dna hybridisation
BR9810844A (en) Process for detecting a microorganism in a test liquid sample, and an assay device for conducting the process
DE69937689D1 (en) STABILIZED TRANSFECTED CELLS FOR THE FINDING OF ACTIVE INGREDIENTS INFLUENCING MRNA STABILITY
AUPO128096A0 (en) Biosensors
WO1991014003A3 (en) Characterization and analysis of polymorphic vntr loci
Ulrich Conservation of DNA damage tolerance pathways from yeast to humans
WO1998007844A3 (en) Screening assay for the identification of agents which alter expression of pth-rp
WO1996017927A3 (en) Reporter cell line
EP0787805A3 (en) Probe compositions for chromosome identification and method
WO2000058521A3 (en) Methods for the identification of reporter and target molecules using comprehensive gene expression profiles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA